# Bristol-Myers Squibb Company (BMY) — Q3-2019 Earnings Results

**Report date:** 2019-10-31 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q3-2019

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 0.88%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.17 | N/A | +4.81% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction. They noted the importance of maintaining momentum in their product offerings.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They emphasized ongoing commitment to innovation and pipeline development.

### Guidance Changes

No guidance updates were provided during the call.

### What It Means

Bristol Myers Squibb's earnings report shows a positive surprise on EPS, which contributed to a slight increase in stock price. The company did not provide revenue figures or future guidance, leaving some uncertainty. Investors may be encouraged by the management's focus on innovation and pipeline strength, despite the lack of detailed financial forecasts.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q3-2019_